首页|前列腺素D2受体拮抗剂关键中间体的工艺改进

前列腺素D2受体拮抗剂关键中间体的工艺改进

扫码查看
前列腺素D2受体拮抗剂是治疗哮喘和过敏性疾病的潜在药物,其关键中间体合成方法尚不成熟.以N-乙酸叔丁酯吲哚和环状苯并磺酰醛亚胺为底物,自制的新型螺环噁唑啉为配体,路易斯酸为催化剂,通过催化的傅克烷基化反应制备了前列腺素D2受体拮抗剂的关键中间体.配体筛选结果表明:不同的配体对反应的收率起到关键作用,其中螺环喹啉噁唑啉配体和三氟甲磺酸锌复合物催化的反应收率最高,且未产生开环结构的双吲哚副产物.通过对反应溶剂、底物物质的量之比和反应温度等反应条件的研究,确定了最佳的反应条件:以二氯甲烷为反应溶剂,N-乙酸叔丁酯吲哚和环状苯并磺酰醛亚胺物质的量之比为1:1,0℃反应时,收率最高可达97%.该工艺反应条件温和,使用了廉价且环境友好的催化剂,避免使用传统工艺中腐蚀性和易制爆物料.
Process Improvement on Synthesis of Prostaglandin D2 Receptor Antagonists Key Intermediate
Prostaglandin D2 receptor antagonists are potential agents for the treatment of asthma and re-lated allergic diseases,and the synthesis of key intermediate has only been rarely reported.Tert-butyl 2-(1H-indol-1-yl)acetate and cyclic N-sulfonyl aldimine were used as substrates through Friedel-Crafts alkylation reaction by using spiro oxazoline ligand and Lewis acid to give prostaglandin D2 receptor an-tagonists key intermediate.In the ligand screening process,we found ligand was the critical factor to get the high yield.The zinc complex of a new spiro quinox ligand was proved to be a suitable catalyst,the reaction gave high yield and without the by-product.The Friedel-Crafts alkylation reaction was studied by exploring reaction solvent,substrate equivalent and temperature to found the optimized reac-tion conditions.The dichloromethane as the solvent at 0 ℃,and tert-butyl 2-(1H-indol-1-yl)acetate:cyclic N-sulfonyl aldimine=1∶1(n∶n),the highest yield of the target product was 97%.The highlights of this method include mild reaction conditions,and the use of cheap and environmen-tally friendly metal catalyst,avoiding the corrosive and explosive materials in traditional methods.

spiro oxazoline ligandprocess improvementprostaglandin D2key intermediateby-product

李延顺、孙仕芹、矫鲁振、王世潇、曹国锐

展开 >

山东科技职业学院生物与化学工程系,山东潍坊 261053

青岛科技大学化工学院,山东青岛 266042

中国海洋大学医药学院,山东青岛 266100

螺环噁唑啉配体 工艺改进 前列腺素D2 关键中间体 副产物

潍坊市科学技术发展计划项目

2022GX044

2024

合成化学
四川省化学化工学会 中国科学院成都有机化学研究所

合成化学

CSTPCD
影响因子:0.42
ISSN:1005-1511
年,卷(期):2024.32(9)